BSC Medical - Gateway to your medical needsNew and Used Medical Equipment

Latest News

Additive Orthopaedics Announces FDA Clearance of their Minimally-Invasive, Intramedullary 3D Printed Bunion Correction System for the Extremities Market
Wed, 21 Jun 2017 15:11:50 GMT

LITTLE SILVER, N.J., June 21, 2017 -- (Healthcare Sales & Marketing Network) -- Additive Orthopaedics, LLC., an orthopaedic device company, today announced that is has received FDA 510(k) clearance for its 3D printed minimally-invasive, intramedullary Bun...
Devices, Orthopaedic, FDA
Additive Orthopaedics, Bunion Correction System, Bunion

Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President and CEO to Commercialize Proprietary Theralink(R) Tumor Biomarker Platform
Wed, 21 Jun 2017 15:09:27 GMT

Dr. Goix brings 20 years of successful healthcare commercialization experience Two posters were presented at ASCO June 3rd, 2017 for Theralink® Breast Cancer GAITHERSBURG, Maryland, June 21, 2017 -- (Healthcare Sales & Marketing Network) -- Avan...
Diagnostics, Oncology, Personnel
Avant Diagnostics, Theralink

Optim LLC Releases Next Generation LED for ENTity(TM) Series Flexible Endoscopes
Wed, 21 Jun 2017 15:05:00 GMT

The company's pioneering ENTity series now available with enhanced, brighter, second generation LED illumination for improved performance STURBRIDGE, Mass., June 21, 2017 -- (Healthcare Sales & Marketing Network) -- Optim LLC, a premier manufacturer of...
Devices, Product Launch
Optim LLC, flexible laryngoscope, laryngoscope

Advanced Sterilization Products Receives FDA Clearance For World's First 30-Minute Biological Indicator For Low Temperature H202 Sterilization
Wed, 21 Jun 2017 12:49:38 GMT

Faster results enable hospitals to test every single cycle to confirm sterility IRVINE, Calif., June 21, 2017 -- (Healthcare Sales & Marketing Network) -- Advanced Sterilization Products (ASP) today announced it has received FDA clearance for its 30-mi...
Devices, FDA
Advanced Sterilization Products, STERRAD VELOCITY, Biological Indicator

Cardiome Announces Licensing Agreement for XYDALBA(TM) (Dalbavancin Hydrochloride) to Support Planned Commercialization in Israel
Wed, 21 Jun 2017 12:41:23 GMT

VANCOUVER, June 21, 2017 -- (Healthcare Sales & Marketing Network) - Cardiome Pharma Corp. (NASDAQ: CRME / TSX:COM) today announced that its affiliate has signed an exclusive license and distribution agreement with Tzamal Medical Ltd. ("Tzamal")...
Biopharmaceuticals, Licensing
Cardiome Pharma, Tzamal Medical, XYDALBA, ABSSSI, dalbavancin

410 Medical Receives Funding from Triangle Venture Alliance (TVA) - A Newly Formed Network Based on Angel Investors tied to Leading North Carolina Universities
Wed, 21 Jun 2017 12:32:07 GMT

410 Medical Marks First Ever Investment by Triangle Venture Alliance DURHAM, N.C., June 21, 2017 -- (Healthcare Sales & Marketing Network) -- 410 Medical, Inc., a medical device company focused on developing innovative technologies for the resuscitatio...
Devices, Venture Capital
410 Medical, LifeFlow

EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference
Wed, 21 Jun 2017 12:24:30 GMT

ST. PAUL, Minn., June 21, 2017 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Scott Shikora, M...
EnteroMedics, vBloc , Neurometabolic Therapy

NCCN Guidelines Compliance for Chest CT Reduces False Positives and Decreases Health Care Spending in Breast Cancer, Study Finds
Tue, 20 Jun 2017 15:23:30 GMT

As published in JNCCN, a Siteman Cancer Center study uncovered potential to significantly improve NCCN Guidelines-concordant care in patients with early-stage breast cancer FORT WASHINGTON, Pa., June 20, 2017 -- (Healthcare Sales & Marketing Network) -...
Devices, Oncology, Radiology
NCCN, NCCN Guidelines, breast MRI, computed tomography

ANI Pharmaceuticals Announces Launch of Diphenoxylate HCl and Atropine Sulfate Tablets
Tue, 20 Jun 2017 15:17:25 GMT

BAUDETTE, Minn., June 20, 2017 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Diphenoxylate HCl and Atropine Sulfate Tablets, 2.5mg/0.025mg. The annual U.S. market for...
Biopharmaceuticals, Generics, Product Launch
ANI Pharmaceuticals, Diphenoxylate, Atropine

Hologic Announces FDA Clearance of Aptima(R) Assay to Detect Herpes Simplex Virus 1 and 2
Tue, 20 Jun 2017 13:08:09 GMT

Aptima HSV 1 & 2 Assay Now Available Alongside Women's Health, Virology Menu on the Fully Automated Panther System MARLBOROUGH, Mass. , June 20, 2017 -- (Healthcare Sales & Marketing Network) -- Hologic, Inc. (Nasdaq: HOLX) announced today that it has ...
Diagnostics, FDA
Hologic, Aptima, Herpes Simplex Virus, Panther

Source: HSMN NewsFeed